Tinnitus Alleviation Via Sensory Stimulation
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The investigators propose that a novel experimental device 'MuteButton' can affect the awareness of tinnitus. Sound that arrives at the ears naturally will be presented in the form of touch patterns on the tongue. By learning to associate the sounds in the ears with the sound patterns on the tongue, the investigators aim to demonstrate that the brain will learn to discriminate the real sounds from legitimate external sounds from the imaginary tinnitus sounds that are created inside the brain. Tinnitus is an audiological condition most commonly described as 'ringing in the ears' that affects an estimated 40 million people globally (American Tinnitus Association; Royal National Institute for Deaf). More accurately, tinnitus is the perception of illusory sound that has no legitimate external source and normally arises from a small number of underlying neuropathologies. There are broadly two categories of tinnitus - Somatic Tinnitus and Hearing Loss Related Tinnitus. MuteButton is indicated for the treatment of permanent intractable subjective tinnitus. The study is intended to show the efficacy of MuteButton treatment in alleviating tinnitus. The objective of the study will be to determine the impact of acoustic and tactile multi-modal neuromodulation on symptoms of permanent intractable tinnitus as measured by objective and subjective measures including Minimum Masking Level (MML), Tinnitus Loudness Masking (Tinnitus Loudness Masking), Tinnitus Handicap Inventory (THI) and Visual Analogue Scale (VAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2012
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 20, 2015
CompletedFirst Posted
Study publicly available on registry
April 27, 2015
CompletedJune 8, 2022
June 1, 2022
4 months
April 20, 2015
June 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tinnitus Handicap Inventory (THI)
Face to face assessment with qualified audiologists every 2 weeks
Change in THI from baseline to 12 weeks
Secondary Outcomes (3)
Visual Analogue Scale (VAS)
Change in VAS from baseline to 12 weeks
Tinnitus Loudness Matching (TLM)
Change in TLM from baseline to 12 weeks
Minimum Masking Level (MML)
Change in MML from baseline to 12 weeks
Study Arms (1)
MuteButton sensory stimulation device
EXPERIMENTALParticipants will be asked to use the Mutebutton, neuro-modulation device every day for 60 minutes for 12 weeks. Use of the device involves placing a 'lollipop' type sensor on the tongue and wearing earphones. The participant will hear "pink noise" through the earphones and will receive neuro-stimulation through the sensor. The participant will not feel any discomfort whilst using the MuteButton device.
Interventions
Participants are asked to use the MuteButton daily for 30-40 minutes. They receive 'pink noise' through headphones and transcutaneous stimulation on the tongue using a 'lollipop' sensor that sits on the anterior section (tip) of the tongue.
Eligibility Criteria
You may qualify if:
- Aged \<65 years
- Suffering from subjective intractable tinnitus
- Tinnitus \> 6 months
- Tinnitus associated with an age or noise related sensory-neural hearing loss
- Have sound English reading, comprehension and written skills
- Able and willing to participate in the study for the 16 weeks duration
- Informed consent
You may not qualify if:
- Ulceration of oral cavity or tongue, oral mucosa or significant intra oral disease - to mitigate risk of further aggravation these symptoms
- Meniere's Disease - due to the fluctuating hearing loss patients normally present with
- Hyperacusis - to avoid further aggravation of sensitivity of sound
- Current medical legal cases regarding tinnitus or hearing - in order to avoid any conflict of interest
- Undergoing any treatment for tinnitus - in order to accurately measure the independent effect of the intervention.
- Pacemakers - due to potential magnetic interference.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Pearlmutter
Study Record Dates
First Submitted
April 20, 2015
First Posted
April 27, 2015
Study Start
June 1, 2012
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
June 8, 2022
Record last verified: 2022-06